|
|
|||||||
Clinical Trial |
Dipartimento di Emato-Oncologia, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy.
The amount of transfused dimethyl sulfoxide (DMSO) is indicated as the major cause of the cryoprotectant-related toxicity in autologous stem cell recipients, with a high incidence of major cardiac side effects. In this study we tried to discover whether fractionated infusion of the total graft volume could prevent the DMSO-related major cardiovascular side effects. We conclude that continuous cardiac monitoring during and after fractionated infusions of DMSO-containing graft documented no major arrhythmias, with only seven episodes of asymptomatic sinus bradycardia.
This article has been cited by other articles:
![]() |
C. Wyns, A. Van Langendonckt, F.-X. Wese, J. Donnez, and M. Curaba Long-term spermatogonial survival in cryopreserved and xenografted immature human testicular tissue Hum. Reprod., November 1, 2008; 23(11): 2402 - 2414. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |